Big Pharma Split Corp Class A (PRM) — Strategic Asset Allocation Index
Big Pharma Split Corp Class A (PRM) has a Strategic Asset Allocation Index of 178.0% as of June 2025. Strategic assets (PP&E of CA$- plus long-term investments of CA$23.40 Million) total CA$23.40 Million, measured against net assets of CA$13.14 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Big Pharma Split Corp Class A Strategic Asset Allocation Index (2017–2024)
This chart shows how Big Pharma Split Corp Class A's Strategic Asset Allocation Index has evolved across 7 annual periods from 2017 to 2024. As of June 2025, the index stands at 178.0%, representing strategic assets of CA$23.40 Million against net assets of CA$13.14 Million CAD. Explore Big Pharma Split Corp Class A cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Big Pharma Split Corp Class A (2017–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Big Pharma Split Corp Class A from 2017 to 2024, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Big Pharma Split Corp Class A (PRM) market capitalisation.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 184.0% | CA$25.17 Million | CA$- | CA$25.17 Million | CA$13.68 Million | ▲ +18.4 pp |
| 2023 | 165.6% | CA$26.25 Million | CA$- | CA$26.25 Million | CA$15.85 Million | ▲ +42.6 pp |
| 2022 | 123.0% | CA$24.27 Million | CA$- | CA$24.27 Million | CA$19.73 Million | ▼ -38.2 pp |
| 2021 | 161.3% | CA$36.13 Million | CA$- | CA$36.13 Million | CA$22.40 Million | ▼ -9.0 pp |
| 2020 | 170.2% | CA$22.45 Million | CA$- | CA$22.45 Million | CA$13.19 Million | ▼ -5.7 pp |
| 2018 | 175.9% | CA$33.14 Million | CA$- | CA$33.14 Million | CA$18.84 Million | ▲ +11.9 pp |
| 2017 | 164.0% | CA$30.63 Million | CA$- | CA$30.63 Million | CA$18.68 Million | — |